Toronto, Ontario–(Newsfile Corp. – December 1, 2021) – Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the “Company” or “Psyched“), a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that on November 30, 2021, representatives from the Company and KGK Science, the Company’s contract research…

Source

Previous articlePsychiatrist and Addiction Researcher, Dr. Henry Kranzler Joins Entheon Advisory Board
Next articleCOMPASS Pathways announces further positive results from groundbreaking phase IIb trial of investigational COMP360 psilocybin therapy for treatment-resistant depression